Healthcare 21, Europe’s leading medical device distributor offering sales, marketing and technical services solutions for many of the world’s leading healthcare equipment manufacturers, today announced that it has formed a new partnership with AngioDynamics in the United Kingdom (U.K.) market.
The new distribution arrangement with AngioDynamics, a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, becomes effective from 1 November 2022. The partnership will include the distribution of AngioDynamics’ leading transformative oncology and surgical product portfolio by Healthcare 21 in the U.K.
Both companies are excited to commence this new partnership, and to work collaboratively to achieve ambitious growth goals and improve patient healthcare outcomes.
“I am ecstatic about the partnership between AngioDynamics and Healthcare21. It enables greater patient access to our oncology and surgical portfolio in the United Kingdom and creates the opportunity to strengthen clinician support programmes in the field. Our company goals and culture are aligned to create a partnership to enhance AngioDynamics’ contribution to the healthcare sector and allow clinicians to treat patients with confidence,” said Laura Piccinini, AngioDynamics Senior Vice President/General Manager – International.
Healthcare 21, part of the AddLife Group, partners with some of the world’s leading healthcare brands and offers detailed local market insight, clinical expertise and well-resourced sales, marketing, operations, and technical services across the UK and Irish healthcare markets. Healthcare 21’s investment in education through the HC21 Academy programme of training events supports the development of strong clinical relationships in the field.
Nathan Pettitt, Healthcare21 Chief Executive Officer, said “The partnership of AngioDynamics and HC21 represents an incredible opportunity for both our organisations. AngioDynamics has been designing and manufacturing high-quality instrumentation since 1988 and is recognised as a leader in its field. We are excited to enhance the accessibility of the AngioDynamics product portfolio in the UK. The experience and talent of the people in both organisations will help ensure significant growth and success for all involved. We are excited to be AngioDynamics’ strategic partner and look forward to achieving our growth potential together.”
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients.
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.